These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Functional validation of tensin2 SH2-PTB domain by CRISPR/Cas9-mediated genome editing. Marusugi K; Nakano K; Sasaki H; Kimura J; Yanobu-Takanashi R; Okamura T; Sasaki N J Vet Med Sci; 2016 Oct; 78(9):1413-1420. PubMed ID: 27246398 [TBL] [Abstract][Full Text] [Related]
5. Deletion of the Tensin2 SH2-PTB domain, but not the loss of its PTPase activity, induces podocyte injury in FVB/N mouse strain. Sasaki H; Takahashi Y; Ogawa T; Hiura K; Nakano K; Sugiyama M; Okamura T; Sasaki N Exp Anim; 2020 Apr; 69(2):135-143. PubMed ID: 31723089 [TBL] [Abstract][Full Text] [Related]
6. Laminin-521 Protein Therapy for Glomerular Basement Membrane and Podocyte Abnormalities in a Model of Pierson Syndrome. Lin MH; Miller JB; Kikkawa Y; Suleiman HY; Tryggvason K; Hodges BL; Miner JH J Am Soc Nephrol; 2018 May; 29(5):1426-1436. PubMed ID: 29472414 [No Abstract] [Full Text] [Related]
7. Genetic loci for resistance to podocyte injury caused by the tensin2 gene deficiency in mice. Takahashi Y; Sasaki H; Okawara S; Sasaki N BMC Genet; 2018 Apr; 19(1):24. PubMed ID: 29636014 [TBL] [Abstract][Full Text] [Related]
11. Role of the podocyte (and glomerular endothelium) in building the GBM. Abrahamson DR Semin Nephrol; 2012 Jul; 32(4):342-9. PubMed ID: 22958488 [TBL] [Abstract][Full Text] [Related]